| Patents for C07D 213 - Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members (63,273) |
|---|
| 02/03/2005 | WO2004094384A3 (hetero) arylamide 2-hydroxy-3-diaminoalkanes for use in the treatment of alzheimer’s disease |
| 02/03/2005 | WO2004085384A3 Bis-aryl sulfonamides |
| 02/03/2005 | WO2004001877A3 Electrolytes for electrooptic devices comprising ionic liquids |
| 02/03/2005 | US20050027120 Method for the synthesis of amides and related products from esters or ester-like compounds |
| 02/03/2005 | US20050027097 Multicolor; light emitting diodes; polyarylenevinylenes |
| 02/03/2005 | US20050026981 Stable oral solid drug composition |
| 02/03/2005 | US20050026965 Pharmaceutical uses and synthesis of nicotinanilide-N-oxides |
| 02/03/2005 | US20050026964 4-(2-Fluoro-4-iodoanilino)-N-(2-hydroxyethoxy)-1-methyl-6-oxo-1,6-dihydro-3-pyridinecarboxamide for treating cancer, restenosis, psoriasis, autoimmune disease, atherosclerosis, rheumatoid arthritis, heart failure, chronic pain, neuropathic pain, or osteoarthritis |
| 02/03/2005 | US20050026952 Nicotinamide derivatives useful as PDE4 inhibitors |
| 02/03/2005 | US20050026942 Chemokine receptor binding heterocyclic compounds |
| 02/03/2005 | US20050026920 Diaryl compounds |
| 02/03/2005 | US20050026914 Pyrimidine or pyridine carbamate compounds as for example 1,1-dimethylethyl 4-(4-((4-((((2,6-dimethylphenyl)oxy)carbonyl)(4-(methyloxy)phenyl)amino)-2-pyrimidinyl)amino)phenyl)-1-piperazinecarboxylate; for the treatment of protein tyrosine kinase-associated disorders |
| 02/03/2005 | US20050026908 Can bind to Prostaglandin E2 receptors, especially, EP3 receptor and/or EP4 receptor and show antagonizing activity, and may be useful for prevention and/or treatment of disease, for example, pain, allergy, Alzheimer's disease, cancer |
| 02/03/2005 | US20050026875 Treating bacterial, viral, or fungal infections, cancer, a lung injury, an eye disorder, neurological disorder or stroke |
| 02/03/2005 | US20050026785 Novel phenyl-propargylether derivatives |
| 02/03/2005 | US20050025997 Luminescent layer between electrodes |
| 02/03/2005 | US20050025992 Organic electroluminescent device based on 2,5-diaminoterephthalic acid derivatives |
| 02/03/2005 | US20050025702 radiotherapeutic or chemotherapeutic agents comprising metalloenzyme inhibitors and chelation compounds capable of conjugating to cytotoxic radioisotopes; anticarcinogenic agents |
| 02/03/2005 | CA2744317A1 Substituted tetracycline compounds |
| 02/03/2005 | CA2538520A1 Preparation and use of alkylating agents |
| 02/03/2005 | CA2534262A1 Nicotinamide derivatives useful as pde4 inhibitors |
| 02/03/2005 | CA2533662A1 Nicotinamide derivatives useful as pde4 inhibitors |
| 02/03/2005 | CA2533603A1 Nicotinamide derivatives useful as pde4 inhibitors |
| 02/03/2005 | CA2532980A1 2-aminopyrimidine and 2-aminopyridine-4-carbamates for use in the treatment of autoimmune diseases |
| 02/03/2005 | CA2532865A1 Fluoro substituted omega-carboxyaryl diphenyl urea for the inhibition of kinase signaling |
| 02/03/2005 | CA2532064A1 Hydroxypyridine cgrp receptor antagonists |
| 02/03/2005 | CA2530302A1 Novel aminobenzophenone compounds |
| 02/03/2005 | CA2530087A1 Radiolabeled cannabinoid-1 receptor modulators |
| 02/03/2005 | CA2529734A1 2-amino-4-hydroxy-5-pyrimidine carboxamide derivatives and related compounds as inhibitors of t cell activation for the treatment of inflammatory diseases |
| 02/03/2005 | CA2529036A1 Indane derivates as muscarinic receptor agonists |
| 02/02/2005 | EP1502576A2 Composition containing a 2-thioacetamide and use thereof for stimulating growth or preventing fall out of keratin fibres |
| 02/02/2005 | EP1501841A2 Non nucleoside reverse transcriptase inhibitors |
| 02/02/2005 | EP1501840A1 Bridged bi-aromatic ligands, complexes, catalysts and processes for polymerizing and polymers therefrom |
| 02/02/2005 | EP1501827A2 Piperidinyl-and piperazinyl-sulfonylmethyl hydroxamic acid and their use as protease inhibitors |
| 02/02/2005 | EP1501815A1 Substituted phenylacetamides and their use as glucokinase activators |
| 02/02/2005 | EP1501814A1 Semicarbazide derivatives for combating thromboembolic diseases |
| 02/02/2005 | EP1501800A1 Bombesin antagonists |
| 02/02/2005 | EP1501791A1 Amino acid analogues |
| 02/02/2005 | EP1501787A1 N-biphenylmethyl aminocycloalkanecarboxamide derivatives with a substiituent on the methyl useful as bradykinin antagonists |
| 02/02/2005 | EP1501508A1 Inhibitors of histone deacetylase |
| 02/02/2005 | EP1414814B1 6-aryl-4-aminopicolinates and their use as herbicides |
| 02/02/2005 | EP1330233B1 Method of treating stroke |
| 02/02/2005 | EP1286955B1 Aryl and heteroarylcyclopropyl oxime ethers and their use as fungicides |
| 02/02/2005 | EP1184376B1 Novel heterocyclic carboxamide derivatives |
| 02/02/2005 | EP1165534B1 Benzoylguanidine derivatives with advantageous properties, method for producing them and their use in the production of medicaments |
| 02/02/2005 | CN1575283A Piperazine derivatives with CCRI receptor antagonist activity |
| 02/02/2005 | CN1575281A Method for producing 2-halogen-pyridine-carboxylic acid amides |
| 02/02/2005 | CN1575280A Urea and thiourea derivatives as non-nucleoside reverse transcriptase inhibitors |
| 02/02/2005 | CN1575279A Substituted thioacetamides |
| 02/02/2005 | CN1575275A Novel alpha-oxygenated or alpha-thiolated carboxylic acid penethylamide derivatives |
| 02/02/2005 | CN1575273A 3, 4-di-substituted cyclobutene-1, 2-diones as CXC-chemokine receptor antagonists |
| 02/02/2005 | CN1575177A Cxcr3 antagonists |
| 02/02/2005 | CN1575171A Novel anti-diabetic agents |
| 02/02/2005 | CN1572792A Pyrazolo [4, 3-d] pyrimidine derivatives |
| 02/02/2005 | CN1572366A Method and apparatus of producing organic compound |
| 02/02/2005 | CN1187338C 5-phenyl-pyrimidine derivatives |
| 02/02/2005 | CN1187048C MGluR 5 antagonists for treatment of pain and anxiety |
| 02/01/2005 | US6849739 N-heterocyclic derivatives as NOS inhibitors |
| 02/01/2005 | US6849733 Compounds containing amidated guanidine derivative type functional group of structure N-C(=N)-N-CO-N-C=N or N-C(=N)-N-CO-N |
| 02/01/2005 | US6849660 Antimicrobial biaryl compounds |
| 02/01/2005 | US6849658 Biaromatic compounds and pharmaceutical and cosmetic compositions comprising them |
| 02/01/2005 | US6849649 N-phenpropylcyclopentyl-substituted glutaramide derivatives as inhibitors of neutral endopeptidase |
| 02/01/2005 | US6849648 Phenylene alkyne matrix metalloproteinase inhibitors |
| 02/01/2005 | US6849634 Potassium channel inhibitors |
| 02/01/2005 | US6849632 Heteroaryl alkyl piperazine derivatives |
| 02/01/2005 | US6849626 Aza-amino acid derivatives (factor Xa inhibitors 15) |
| 02/01/2005 | US6849624 Headaches; antiarthritic agents; respiratory system disorders; psychological disorders |
| 02/01/2005 | US6849618 Herbicidal compositions for the desiccation/ defoliation of plants |
| 02/01/2005 | CA2183976C Process for making an epoxide |
| 01/27/2005 | WO2005007627A1 Phenylpyridine derivative, intermediate therefor, and herbicide containing the same as active ingredient |
| 01/27/2005 | WO2005007621A2 Ubiquitin ligase inhibitors |
| 01/27/2005 | WO2005007618A1 Method for production of $g(a),$g(b)-unsaturated amide compounds |
| 01/27/2005 | WO2005007616A1 Diphenylamino ketone derivatives as mek inhibitors |
| 01/27/2005 | WO2005007601A2 Substituted arylthiourea derivatives useful as inhibitors of viral replication |
| 01/27/2005 | WO2004091613A3 Substituted phenyl acetamides and their use as protease inhibitors |
| 01/27/2005 | WO2004069794B1 New arylpiperazinyl compounds |
| 01/27/2005 | WO2004064972A3 Capture compounds, collections thereof and methods for analyzing the proteome and complex compositions |
| 01/27/2005 | US20050020831 Acylthiols and component thiol compositions as anti-hiv and anti-retroviral agents |
| 01/27/2005 | US20050020684 Modulators of peroxisome proliferator activated receptors |
| 01/27/2005 | US20050020651 Butyric acid derivatives |
| 01/27/2005 | US20050020643 Controlling plant disease, fung |
| 01/27/2005 | US20050020642 Antiinflammatory agents; antiarthritic agents; anticancer agents; angiogenesis inhibitors; asthma therapy; cyclooxygenase inhibitor |
| 01/27/2005 | US20050020590 Antiinflammatory agents; autoimmune disease; bone disorders; viricides; antiproliferative agents; antiarthritic agents |
| 01/27/2005 | US20050020576 Opioid antagonist; analgesics; antiinflammatory agents; side effect reduction |
| 01/27/2005 | US20050020540 Biphenylcarboxylic amide derivatives as p38-kinase inhibitors |
| 01/27/2005 | US20050020521 In vivo gene silencing by chemically modified and stable siRNA |
| 01/27/2005 | US20050020450 Novel alpha-oxygenated or alpha-thiolated carboxylic acid penethylamide derivatives |
| 01/27/2005 | US20050019278 Block solar radiation; applying to skin, hair |
| 01/27/2005 | CA2531603A1 Method for production of .alpha., .beta.-unsaturated amide compounds |
| 01/26/2005 | EP1500651A1 N-[2-(2-Pyridinyl)ethyl]benzamide compounds and their use as fungicides |
| 01/26/2005 | EP1500650A1 Pyridine compounds or salts thereof and herbicides containing the same |
| 01/26/2005 | EP1500649A1 Process for performing an in-situ-quench reaction |
| 01/26/2005 | EP1500643A1 Benzamide derivatives |
| 01/26/2005 | EP1499624A1 Electroluminescent materials |
| 01/26/2005 | EP1499592A1 Amlodipine nicotinate and process for the preparation thereof |
| 01/26/2005 | EP1499591A1 Carboxylic acid amides |
| 01/26/2005 | EP1499583A1 Process for preparing highly functionalized y-butyrolactams and y-amino acids |
| 01/26/2005 | EP1499578A2 Prime ring substituted thyroid receptor antagonists for the treatment of cardiac and metabolic disorders |
| 01/26/2005 | EP1499312A1 The use of hydroxypyridone-derivatives in wound healing |
| 01/26/2005 | EP1243579B1 Process for the production of pyridine derivatives |